Literature DB >> 2075615

Human hepatic cortisol reductase activities: enzymatic properties and substrate specificities of cytosolic cortisol delta 4-5 beta-reductase and dihydrocortisol-3 alpha-oxidoreductase(s).

R B Iyer1, J M Binstock, I S Schwartz, G G Gordon, B I Weinstein, A L Southren.   

Abstract

The metabolism of cortisol by human liver homogenates has been studied. Cortisol delta 4-reductase and dihydrocortisol-3-oxidoreductase activities were distributed in all subcellular fractions. The products of the soluble enzymes were identified. Cortisol and 5 beta-dihydrocortisol were reduced to 3 alpha,5 beta-tetrahydrocortisol, and 5 alpha-dihydrocortisol was reduced to 3 alpha,5 alpha-tetrahydrocortisol. The soluble enzymes showed a wide range of substrate specificity. The 21 substituted cortisol derivatives were not metabolized. The apparent Km values of cortisol delta 4-5 beta-reductase and dihydrocortisol-3 alpha-oxidoreductase for their substrates (cortisol, 5 alpha-dihydrocortisol, and 5 beta-dihydrocortisol) all ranged from 18 to 27 microM. Dexamethasone inhibited the reduction of all of these substrates and the inhibition was abolished by 21 substitution of the dexamethasone. Testosterone was a competitive inhibitor of the reduction of cortisol, 5 alpha-dihydrocortisol, and 5 beta-dihydrocortisol with a Ki ranging from 11 to 32 microM. NADPH was the preferred cofactor for the cortisol delta 4-5 beta-reductase and dihydrocortisol-3 alpha-oxidoreductase. No end product inhibition was observed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2075615     DOI: 10.1016/0039-128x(90)90087-r

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  6 in total

1.  The effect of disease associated point mutations on 5β-reductase (AKR1D1) enzyme function.

Authors:  Rebekka Mindnich; Jason E Drury; Trevor M Penning
Journal:  Chem Biol Interact       Date:  2010-12-24       Impact factor: 5.192

2.  Substrate specificity and inhibitor analyses of human steroid 5β-reductase (AKR1D1).

Authors:  Mo Chen; Jason E Drury; Trevor M Penning
Journal:  Steroids       Date:  2011-01-19       Impact factor: 2.668

3.  Evidence for the involvement of 3-oxo-delta 4 intermediates in ecdysteroid biosynthesis.

Authors:  C Blais; C Dauphin-Villemant; N Kovganko; J P Girault; C Descoins; R Lafont
Journal:  Biochem J       Date:  1996-12-01       Impact factor: 3.857

Review 4.  Role of aldo-keto reductase family 1 (AKR1) enzymes in human steroid metabolism.

Authors:  Tea Lanišnik Rižner; Trevor M Penning
Journal:  Steroids       Date:  2013-11-01       Impact factor: 2.668

5.  iTRAQ-based quantitative proteomic analyses the cycle chronic heat stress affecting liver proteome in yellow-feather chickens.

Authors:  Quan Zhang; YuZe Yang; YongQiang Lu; ZiWen Cao
Journal:  Poult Sci       Date:  2021-03-17       Impact factor: 3.352

6.  Improved Urinary Cortisol Metabolome in Addison Disease: A Prospective Trial of Dual-Release Hydrocortisone.

Authors:  Stéphanie Espiard; Johanna McQueen; Mark Sherlock; Oskar Ragnarsson; Ragnhildur Bergthorsdottir; Pia Burman; Per Dahlqvist; Bertil Ekman; Britt Edén Engström; Stanko Skrtic; Jeanette Wahlberg; Paul M Stewart; Gudmundur Johannsson
Journal:  J Clin Endocrinol Metab       Date:  2021-03-08       Impact factor: 5.958

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.